About Canopy Growth Corporation (CGC)
The Cannabis industry is huge and continues to grow fast thus attracting hundreds of new businesses. Canopy Growth Corporation (CGC) is one of the leading companies in the cannabis industry today. With over ten years in the market, they worked their way up to a successful cannabis business. And this is huge, especially because the cannabis market is still evolving, has endless gaps in regulation, and has a long way to maturity.
Canopy Growth Corporation is one of those forward-thinking and innovative companies that can fill these gaps. The CGC team has been succeeding for years and here is why. In this Canopy Growth review, we will cover every aspect of the company: history, products, contact information, location, and more.
Canopy Growth Corporation is a North American cannabis company that was founded in 2014. It has become the first official North-American trader and now it is listed on the Toronto Stock Exchange. During the past ten years, CGC has opened the subsidiary companies – Tweed Inc, Bedrocan Canada Inc, Tweed Farms Inc, and Mettrum Health Corp – and continued to expand its business. CGC produces and distributes cannabis to the Canadian medical and recreational market. Also, the company operates with other brand names such as Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria.
Every subsidiary of the Canopy Growth Corporation is focused on growing and selling medical cannabis both domestically and internationally. In 2016 they started selling their products in Germany and Brazil. Some of their products include:
- Dried Flowers
- Oils and Concentrates
- Soft gel Capsules
Tweed and Bedrocan, the main subsidiaries of the company, have transformed into reliable cannabis brands in Canada. Tweed is now having a commercial license to produce marijuana. Also, this license encompasses the company’s 168,000 square feet of Smiths Falls facility. Due to this license and size of its production facility, Tweed is able to manufacture and sell over 3,540 kilograms of medical marijuana per year.
The Bedrocan subsidiary also produces medical cannabis. In Toronto and Ontario, it has a manufacturing facility of 52,000 square feet, which includes 30 vegetative and growing rooms.
Canopy Growth Corporation is involved in a partnership research program with NEEKA Health Canada. This collaboration helps to study the effects on human health, in particular post-concussion neurological diseases that ex NHL players have. Also, they help in treating chronic pain, seizures, muscle spasms, nausea, and loss of appetite.
CGC has grown to be the biggest clinical cannabis company in the world. They happen to be the first publicly-traded weed company on the Toronto Stock Exchange (August 2016) and the New York Stock Exchange (May 2018). They have the license (operating ten licensed cannabis production sites) and the large production facilities; hence they dominate the industry. Also, the company keeps expanding its territory by acquiring Hiku brands.
In Canada, where the company started, they already have 4.4 million square feet of licensed production space and over 1.3 million square feet of development space. Also, they operate in 12 countries on five continents.